loadpatents
name:-0.016902923583984
name:-0.018245935440063
name:-0.00064301490783691
Gibeau; Craig R. Patent Filings

Gibeau; Craig R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gibeau; Craig R..The latest application filed is for "pyrrolotriazine inhibitors of irak4 activity".

Company Profile
0.19.23
  • Gibeau; Craig R. - Boston MA
  • Gibeau; Craig R. - Holliston MA US
  • Gibeau; Craig R. - Natick MA
  • Gibeau; Craig R. - Arlington MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Tricyclic compounds as inhibitors of mutant IDH enzymes
Grant 10,508,108 - Fischer , et al. Dec
2019-12-17
Pyrrolotriazine inhibitors of IRAK4 activity
Grant 10,329,295 - Lim , et al.
2019-06-25
Pyrazolopyrimidine inhibitors of IRAK4 activity
Grant 10,329,294 - Lim , et al.
2019-06-25
Carboxamide inhibitors of IRAK4 activity
Grant 10,155,765 - Lim , et al. Dec
2018-12-18
Pyrrolopyridazine inhibitors of IRAK4 activity
Grant 10,040,798 - Lim , et al. August 7, 2
2018-08-07
Thienopyrazine inhibitors of IRAK4 activity
Grant 10,040,802 - Lim , et al. August 7, 2
2018-08-07
Inhibitors of IRAK4 activity
Grant 9,969,749 - Altman , et al. May 15, 2
2018-05-15
Inhibitors of IRAK4 activity
Grant 9,943,516 - Altman , et al. April 17, 2
2018-04-17
Inhibitors of IRAK4 activity
Grant 9,932,350 - Altman , et al. April 3, 2
2018-04-03
Inhibitors of IRAK4 activity
Grant 9,926,330 - Altman , et al. March 27, 2
2018-03-27
Carboxamide Inhibitors Of Irak4 Activity
App 20180051027 - LIM; JONGWON ;   et al.
2018-02-22
Thienopyrazine Inhibitors Of Irak4 Activity
App 20180051035 - LIM; JONGWON ;   et al.
2018-02-22
Pyrrolopyridazine Inhibitors Of Irak4 Activity
App 20180051029 - LIM; JONGWON ;   et al.
2018-02-22
Pyrazolopyrimidine Inhibitors Of Irak4 Activity
App 20180051028 - LIM; JONGWON ;   et al.
2018-02-22
Pyrrolotriazine Inhibitors Of Irak4 Activity
App 20180051030 - LIM; JONGWON ;   et al.
2018-02-22
Novel Tricyclic Compounds As Inhibitors Of Mutant Idh Enzymes
App 20170369507 - Christian; Fischer ;   et al.
2017-12-28
Novel Tricyclic Compounds As Inhibitors Of Mutant Idh Enzymes
App 20170362220 - Fischer; Christian ;   et al.
2017-12-21
Inhibitors Of Irak4 Activity
App 20170275297 - ALTMAN; MICHAEL D. ;   et al.
2017-09-28
Inhibitors Of Irak4 Activity
App 20170247388 - ALTMAN; MICHAEL D. ;   et al.
2017-08-31
Inhibitors Of Irak4 Activity
App 20170217981 - ALTMAN; MICHAEL D. ;   et al.
2017-08-03
Inhibitors Of Irak4 Activity
App 20170209446 - ALTMAN; MICHAEL D. ;   et al.
2017-07-27
Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
Grant 9,221,809 - Seganish , et al. December 29, 2
2015-12-29
Substituted piperidines as HDM2 inhibitors
Grant 9,062,071 - Ma , et al. June 23, 2
2015-06-23
SUBSTITUTED PIPERIDINES THAT INCREASE p53 ACTIVITY AND THE USES THEREOF
App 20140336222 - Bogen; Stephane L. ;   et al.
2014-11-13
Substituted Piperidines As Hdm2 Inhibitors
App 20140323482 - Ma; Yao ;   et al.
2014-10-30
Substituted piperidines that increase p53 activity and the uses thereof
Grant 8,859,776 - Bogen , et al. October 14, 2
2014-10-14
Substituted Piperidines That Increase P53 Activity And The Uses Thereof
App 20120208844 - Bogen; Stephane L. ;   et al.
2012-08-16
Substituted piperidines that increase P53 activity and the uses thereof
Grant 7,884,107 - Ma , et al. February 8, 2
2011-02-08
Substituted Piperidines that Increase P53 Activity and the Uses Thereof
App 20080004287 - Ma; Yao ;   et al.
2008-01-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed